Press Releases 2012

Boston Scientific WATCHMAN™ Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use - Aug 26, 2012

European regulators have approved an expanded indication for the Boston Scientific Corporation (NYSE: BSX) WATCHMAN® Left Atrial Appendage (LAA) Closure Device. The new indication...

Read more

Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device - Jul 02, 2012

Boston Scientific Corporation (NYSE: BSX) has completed enrollment in the PREVAIL confirmatory study, designed to gain U.S. Food and Drug Administration (FDA) approval for the...

Read more

Media Contacts

Rosie Ireland
Corporate Communications
+44 7585403359

Company Profile